← Eichor
Study identifier: NCT03813862 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Observational Pharmaco-Epidemiology Research & Analysis

Condition: Chronic Disease · HIV/AIDS · Liver Diseases  ·  Sponsor: Epividian

PhaseN/A
Planned participants2000000
Who can joinAll sexes, 0 Years to no upper limit
Healthy volunteersYes

About this study

Greater advances are needed in two separate but related areas in healthcare: 1) the Clinical Decision Support Systems that complement the EHR use in support of routine patient care, population management and disease management; and 2) the use of the point-of-care observational data from the provider-patient encounter that support realworld medical research and healthcare quality measure assessment. Real-world evaluations of treatments of chronic diseases in the context of comorbid conditions and special populations (minorities, women, mentally ill, and those with addiction) are limited. The purpose of the OPERA database is to help address this unmet need in clinical research.

This description comes directly from the study's public registry record.

Talk to the study team

Gregory Fusco, MD  ·  224-632-1862  ·  gregory.fusco@epividian.com

Always discuss trial participation with your own doctor first.

Locations (1)

EpividianDurham, North Carolina, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03813862